-
Published 6/3/2026
Truong V, Kekibiina A, Muyindike WR, Gnatienko N, Tsui JI, Emenyonu NI, Cheng DM, Hahn JA, Allison O, Bullard MJ, Lunze K, Samet JH. Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL). Trials. 2026 Jun 03. PMID: 42237416.
-
Published 5/28/2026
Rossi SL, Cheng DM, Sereda Y, Truong V, Carroll JJ, Kiriazova T, Lodi S, Michals A, Raj A, Krupitsky E, Lioznov D, Samet JH, Lunze K. COVID-19 pandemic-related stress and substance use behaviors among people with HIV - a mixed method analysis. PLoS One. 2026; 21(5):e0349567. PMID: 42207818.
-
Published 1/18/2026
Rich ZC, Tindle HA, Cheng DM, Stein MD, Gnatienko N, Bendiks S, Forman L, Patts GJ, Krupitsky E, Freiberg MS, Samet JH. Assessing the impact of nicotinic partial agonists compared to NRT on opioid and cigarette use: A secondary analysis investigating treatment outcomes for co-occurring nicotine and opioid use. J Subst Use Addict Treat. 2026 May; 184:209904. PMID: 41558587.
-
Published 10/15/2025
Truong V, Kekibiina A, Muyindike W, Gnatienko N, Tsui JI, Emenyonu NI, Cheng DM, Hahn J, Allison O, Bullard MJ, Lunze K, Samet JH. Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL). Res Sq. 2025 Oct 15. PMID: 41282191.
-
Published 10/11/2025
El-Bassel N, Samet JH, Cheng DM, Freisthler B, John Winhusen T, Walsh SL. Response to the Editor: Re: registration and multiple outcome testing in the HEALing Communities Study by Dennis M. Gorman and Ben G. Fitzpatrick. Int J Drug Policy. 2025 Nov; 145:105029. PMID: 41077014.